Packaging supplier Silgan's Q4 EPS beats estimates on demand for dispensing products

Reuters
02/04
Packaging supplier Silgan's Q4 EPS beats estimates on demand for dispensing products

Overview

  • Packaging supplier's Q4 revenue slightly beat analyst expectations

  • Adjusted EPS for Q4 beat analyst expectations

  • Company returned approximately $160 mln to shareholders

Outlook

  • Silgan expects 2026 adjusted EPS between $3.70 and $3.90

  • Company projects 2026 free cash flow around $450 mln vs $445.2 mln in 2025

  • Silgan sees 2026 capital expenditures of $310 mln vs $307.1 mln in 2025

Result Drivers

  • DISPENSING PRODUCTS - Sales grew over 30% in 2025, driven by customer focus and innovation, despite challenges in personal and home care markets

  • METAL CONTAINERS - 7% growth in pet food markets offset isolated customer development, contributing to segment stability

  • CUSTOM CONTAINERS - Lower volumes due to exit from lower margin business impacted segment sales

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Sales

Slight Beat*

$1.47 bln

$1.46 bln (10 Analysts)

Q4 Adjusted EPS

Beat

$0.67

$0.64 (11 Analysts)

Q4 Net Income

$18.20 mln

Q4 Basic EPS

$0.17

Q4 Gross Profit

$252.70 mln

Q4 Pretax Profit

$53.40 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the non-paper containers & packaging peer group is "buy"

  • Wall Street's median 12-month price target for Silgan Holdings Inc is $49.00, about 12% above its February 3 closing price of $43.76

  • The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release: ID:nBw3n9Xz0a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10